Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Does the G-Shot hurt and is numbing/anaesthetic used?
Pain worries are understandable with any intimate injection. A useful answer should avoid both alarm and “painless” marketing, and explain what patients may realistically feel.
Direct answer
The G-Shot is commonly performed with topical or local anaesthetic to reduce discomfort, but sensation varies. Patients may feel pressure from positioning or a speculum, stinging from anaesthetic, brief injection discomfort, or mild soreness afterwards. It should not be sold as completely painless. Severe, worsening pain, heavy bleeding, fever, offensive discharge or urinary difficulty after treatment should prompt medical advice.
A careful consultation helps separate marketing language from the clinical question: what is being treated, why this option is being considered, what alternatives exist, and what risks or limitations apply.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.

At a glance
These are the key points to understand before considering pain and numbing.
At a glance
Pain and numbing
What it is
A temporary internal filler procedure, usually using hyaluronic acid in the anterior vaginal wall.
Comfort
Topical or local anaesthetic may reduce discomfort, but pressure or stinging can occur.
Evidence status
High-quality evidence is limited, so claims should stay cautious and consent-led.
Afterwards
Mild soreness or spotting can occur; severe pain should be reviewed.
Important suitability note
Severe, worsening or persistent pain after treatment should be assessed promptly.
Numbing
Pressure
Spotting
Aftercare
Detailed answer
What the procedure may feel like
Comfort depends on anatomy, anxiety, pelvic-floor tone, inflammation, previous pain and the anaesthetic approach used.
Clinical context
The most honest wording is usually “managed with anaesthetic” rather than “painless”. That helps patients prepare without being frightened.
Evidence
Consent
Alternatives
Before treatment
The clinician may use topical numbing cream, local anaesthetic or both, depending on protocol.
During placement
Patients may notice pressure, speculum awareness, brief stinging or a short sharp sensation.
Afterwards
Mild tenderness, swelling, spotting or a bruised feeling can occur and should settle.
Not normal
Severe or worsening pain, fever, offensive discharge or urinary retention needs prompt advice.
What this means in practice
The G-Shot is best discussed as a temporary, elective intimate filler procedure with limited high-quality evidence and variable patient-reported outcomes.
If the main concern is pain, dryness, low libido, trauma, infection symptoms or pelvic-floor dysfunction, another assessment pathway may be more appropriate first.
Patient safety
Why proper assessment matters
Patients may already feel embarrassed or tense. Clear sensory expectations help them feel prepared and make it easier to recognise symptoms that are outside normal recovery.
It clarifies the goal
The clinician should identify whether the concern is local sensation, pain, dryness, libido, orgasm difficulty, confidence or a mixture of factors.
It protects safety
Severe, worsening or persistent pain after treatment should be assessed promptly.
It separates treatments
G-Shot, O-Shot, PRP and intimate filler are often discussed together online, but they are not interchangeable.
It sets expectations
Any potential benefit is temporary and individual. Non-response should lead to review rather than automatic repeat treatment.
A careful decision is more useful than a quick label
The strongest consultation explains the treatment aim, the uncertainty, the side effects, the alternatives and the plan if symptoms do not improve.
That approach is especially important for intimate symptoms, where anatomy, comfort, hormones, arousal, pain and confidence can overlap.
Considerations
What to consider before booking
Tell the clinician about vaginismus, vulvodynia, previous painful examinations, trauma history, active irritation or pelvic-floor spasm before deciding whether the procedure is appropriate.
Consultation priorities
Consultation: The patient meets with the practitioner to discuss their sexual gratification goals and undergoes an evaluation. Note: Ethical guidelines suggest this stage should include a frank discussion about normal genital variation and potential underlying dysfunctions.
Consent
Aftercare
Follow-up
Before treatment
A consultation should screen for infection, unexplained bleeding, pregnancy, breastfeeding, pelvic pain, urinary symptoms and expectations.
During the procedure
Depending on protocol, care may include positioning, cleansing, topical or local anaesthetic, careful filler placement and immediate aftercare advice.
Aftercare
Patients should receive written guidance on pelvic rest, sex, tampons, hygiene, activity and symptoms that need medical advice.
When to reassess
Persistent pain, urinary symptoms, filler concerns, dissatisfaction or lack of benefit should lead to review before any further treatment.
Practical expectations
Procedure Duration: The actual clinical appointment and injection process typically take less than half an hour.
Pricing and treatment plans should be confirmed with the clinic or current pricing page before booking; they should not be guessed from competitor pages.
Common concerns and myths
Common misunderstandings
G-Shot content online can be promotional, so the final page should correct simple claims with balanced clinical context.
Myth: it is always painless
Reality: Anaesthetic may reduce discomfort, but some pressure, stinging or soreness can still happen.
Myth: pain afterwards is always normal
Reality: Mild soreness can be expected; severe, worsening or persistent pain should be reviewed.
Myth: numbing removes every concern
Reality: Comfort is only one part of suitability; anatomy, symptoms, risk and expectations still matter.
Evidence and uncertainty
Professional commentary on female genital cosmetic procedures supports cautious claims, explicit consent and honest discussion of limited evidence.
Alternatives and combined care
Depending on the concern, alternatives may include pelvic-health assessment, menopause care, psychosexual support, pain assessment or choosing no procedure.
Safety checklist
Safety checklist
Use these questions to decide whether the next step should be consultation, further assessment, treatment planning or medical review.
Has the concern been defined?
Be clear whether the issue is sensation, orgasm, libido, pain, dryness, confidence, anatomy or something else.
Are red flags absent?
Severe, worsening or persistent pain after treatment should be assessed promptly.
Are options clear?
Ask how G-Shot differs from O-Shot, PRP, labial filler, pelvic-floor care and medical treatment for symptoms.
Is follow-up planned?
You should know what to expect, what aftercare to follow, when to seek help and how response will be reviewed.
Reassuring signs
It is more reasonable to discuss treatment when goals are clear, red flags are absent, expectations are realistic and aftercare is understood.
Realistic goals
Aftercare clear
Reasons to pause
Severe, worsening or persistent pain after treatment should be assessed promptly.
Infection signs
Urinary change
When to escalate
When to seek medical help
Some symptoms should be assessed promptly before or after any elective intimate treatment. Use NHS 111 online
Severe or worsening pain
Seek medical advice if pelvic, vulval or vaginal pain is severe, sudden, worsening or unexplained.
Bleeding or discharge
Unexplained bleeding, heavy bleeding, bleeding after sex, foul-smelling discharge or unusual discharge should be reviewed.
Infection or urinary symptoms
Fever, feeling unwell, worsening swelling, offensive discharge, burning urine or difficulty passing urine needs prompt advice.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or severe sudden illness.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
Regulatory resources
Authoritative resources
These resources support cautious, evidence-aware discussion of G-Shot, G-spot amplification and female genital cosmetic procedures.
DermNet: female genital cosmetic surgery
DermNet summarises female genital cosmetic surgery, including professional caution around G-spot amplification until stronger evidence is available.
RACGP female genital cosmetic surgery toolkit
This professional toolkit explains that commercial terms such as G-Shot can create confusion and that evidence and risks should be discussed clearly.
ASPS overview of O and G shots
ASPS gives a concise professional distinction between PRP-based O-Shot terminology and filler-based G-Shot terminology.
Next step
Book a clinical consultation
A consultation can confirm whether the G-Shot is worth discussing, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 66 imported records. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. G-Shot treatment is an elective, off-label intimate filler procedure in this context, and suitability must be confirmed after individual consultation. Results vary. Not a cure.
